drugset / Trial / NCT07756255

A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescents With ADHD

NCT07756255 ↗

RandomizedFactorialQuadruple-blindTreatment

Summary

The primary goals of this phase 2 clinical trial are to determine the feasibility, safety, and tolerability of oral Fecal Microbiota Transplantation (FMT) in adolescents (aged 13-17) with Attention-Deficit/Hyperactivity Disorder (ADHD).

Timeline

Start
2026-08-31
Primary completion
2028-08-31
Completion
2029-08-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fecal Microbiota Transplantation Other / unclassified 20 unknown Oral
Subject Nitazoxanide Other / unclassified 500 mg Oral
Subject Vancomycin Other / unclassified 250 mg Oral
Background Sodium Picosulfate Unknown 1.5 unknown Oral